At the time of writing, Soleno Therapeutics Inc [SLNO] stock is trading at $49.34, up 0.63%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SLNO shares have gain 10.18% over the last week, with a monthly amount drifted -1.81%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stifel reaffirmed its Buy rating on December 02, 2024, and kept the price target unchanged to $74. On December 02, 2024, Robert W. Baird reiterated its Outperform rating but maintained its price target of $72 on the stock. H.C. Wainwright started tracking the stock assigning a Buy rating and suggested a price target of $70 on September 03, 2024. Robert W. Baird initiated its recommendation with a Outperform and recommended $72 as its price target on May 10, 2024. Piper Sandler started tracking with a Overweight rating for this stock on February 05, 2024, and assigned it a price target of $93. In a note dated January 23, 2024, Stifel initiated an Buy rating and provided a target price of $63 on this stock.
For the past year, the stock price of Soleno Therapeutics Inc fluctuated between $36.61 and $60.92. Currently, Wall Street analysts expect the stock to reach $72 within the next 12 months. Soleno Therapeutics Inc [NASDAQ: SLNO] shares were valued at $49.34 at the most recent close of the market. An investor can expect a potential return of 45.93% based on the average SLNO price forecast.
Analyzing the SLNO fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.53, Equity is -0.75 and Total Capital is -0.59. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 48.44 points at the first support level, and at 47.54 for the second support level. However, for the 1st resistance point, the stock is sitting at 50.24, and for the 2nd resistance point, it is at 51.13.
Ratios To Look Out For
It is important to note that Soleno Therapeutics Inc [NASDAQ:SLNO] has a current ratio of 15.68. As well, the Quick Ratio is 15.68, while the Cash Ratio is 4.69.
Transactions by insiders
Recent insider trading involved Yen Kristen,, that happened on Jan 02 ’25 when 2520.0 shares were sold., Yen Kristen completed a deal on Jan 03 ’25 to sell 2340.0 shares. Meanwhile, CHIEF FINANCIAL OFFICER Mackaness James H sold 4083.0 shares on Jan 02 ’25.
